Stay updated on Magrolimab Combo in Untreated MDS: Clinical Trial
Sign up to get notified when there's something new on the Magrolimab Combo in Untreated MDS: Clinical Trial page.

Latest updates to the Magrolimab Combo in Untreated MDS: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedSite revision updated from v3.4.1 to v3.4.2, indicating a minor internal update.SummaryDifference0.0%

- Check20 days agoChange DetectedRemoved Revision: v3.4.0 and added Revision: v3.4.1.SummaryDifference0.0%

- Check27 days agoChange DetectedGlossary toggle added to the page. Footer/meta text updated to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while capitalization changes were made to 'No FEAR Act Data' and related labels.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page revision was updated from v3.3.3 to v3.3.4; this is a metadata update and does not alter study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe Locations section was expanded with numerous new sites in the US and Australia and a revision label (v3.3.3) was added; several existing locations were removed.SummaryDifference1%

- Check92 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not pertain to the study, and updated the revision label from v3.2.0 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Magrolimab Combo in Untreated MDS: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab Combo in Untreated MDS: Clinical Trial page.